Seven Bridges Selected by Pfizer to Support Data Management Solution for Single-Cell RNA Sequencing Data

Project Underscores Growing Importance of Efficient Genomic Data Management, Visibility and Retrieval BOSTON –  Seven Bridges, the industry-leading bioinformatics ecosystem provider, is supporting Pfizer Inc. (NYSE: PFE) in the development of a data management and collaboration solution for the biopharmaceutical company’s single-cell ribonucleic acid (RNA) sequencing (scRNASeq) data. The Seven Bridges Platform is a cloud-based [...]

Pressure BioSciences and The Ohio State University Announce Food Industry Consortium to Advance Commercialization of PBI’s Ultra Shear Technology

Academia-Industry Partnership to Support Improvements in UST Applications and Allow Global Food Companies Access to UST for Preparation of Safer, More Nutritious Liquid Foods and Beverages SOUTH EASTON, Mass. --Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the [...]

10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event

Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms:  Chromium Single Cell, Visium Spatial, and In [...]

Polymer Factory approved for listing at Spotlight Stock Market, publishes memorandum

Polymer Factory Sweden AB today announces that Spotlight Stock Market’s listing committee has approved Polymer Factory’s application for admission to trading of the Company’s shares and warrants on Spotlight Stock Market. Polymer Factory is, prior to the planned listing, conducting an issue of units (shares and free of charge warrants) amounting to a total of [...]

CVC Credit supports further growth at Calibre Scientific with an incremental $57 million multicurrency credit facility

Funding by CVC Credit has supported five acquisitions since June 2020 CVC Credit is pleased to announce that it has further supported life sciences and diagnostics business, Calibre Scientific, by leading an incremental $57 million multicurrency first lien credit facility to help fuel its ongoing global acquisition strategy. Calibre Scientific is owned by investment firm [...]

ibidi Product News: Culture Cells on a 3D Gel With Defined Flow

Munich, Germany – ibidi’s new µ-Slide I Luer 3D is an innovative slide with one channel and three wells for 3D cell culture under flow. Sample preparation is easy: fill each of the three wells with a gel (e.g., collagen, Matrigel, or fibrinogen). Then, simply seed the cells into the channel, where they will adhere to [...]

Merck KGaA, Darmstadt, Germany and Transylvanian Institute of Neuroscience Cooperate on Brain-Inspired Artificial Intelligence

Merck KGaA, Darmstadt, Germany today announced a three-year collaboration with the Transylvanian Institute of Neuroscience (TINS), based in Cluj-Napoca, Romania Three-year collaboration in fundamental research Partners to conduct research on the fundamental principles of intelligence Darmstadt, Germany – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced today announced a three-year collaboration [...]

908 Devices Appoints Jeff George and Fenel Eloi to its Board of Directors

Company adds two directors with financial, pharmaceutical, and consumable business expertise BOSTON --  908 Devices Inc. (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it has appointed Jeff George and Fenel Eloi to serve on its Board of Directors, effective immediately. Mr. George brings more than two decades of global [...]

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents Dublin, Ireland and Seoul, Korea: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and G+FLAS Life Sciences, Inc. (G+FLAS), a biotechnology company developing research tools and reagents associated with CRISPR [...]

Optibrium appoints Dr Rae Lawrence as Director of Software Development

CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Rae Lawrence as Director of Software Development. With the continued success of the Company’s portfolio of cheminformatics and AI-based drug discovery software, and the recent backing by Kester Capital, Optibrium has made the new appointment to drive its product development [...]

Access IBO on Knowledge Center